Lv31
316 积分 2020-05-31 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
27分钟前
待确认
Enhancing in vivo B cell gene delivery using targeted lentiviral vectors and transduction enhancers
25天前
已完结
Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer
1个月前
已完结
Down-regulation of ABCC11 protein (MRP8) in human breast cancer
1个月前
已关闭
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
2个月前
已完结
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
2个月前
已完结
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
2个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
2个月前
已完结
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
2个月前
已完结
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma
2个月前
已完结
皖公网安备34019202002308
